Spartin (SPART) (Internal Region) 抗体
Quick Overview for Spartin (SPART) (Internal Region) 抗体 (ABIN570717)
抗原
适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
抗原表位
- Internal Region
-
原理
- SPARTIN
-
序列
- EASGTDVKQL DQGNK
-
交叉反应
- 人
-
纯化方法
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
免疫原
- Peptide with sequence C-EASGTDVKQLDQGNK, from the internal region of the protein sequence according to NP_055902.1.
-
亚型
- IgG
-
-
-
-
应用备注
-
Western Blot: Approx 70 kDa band observed in lysates of cell line HeLa (calculated MW of 72.8 kDa according to NP_055902.1). Recommended concentration: 1-3 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:8000.
-
说明
-
Immunofluorescence: HeLa show dimished signals after knock down of expresssion by introduction of siRNA.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.5 mg/mL
-
缓冲液
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Minimize freezing and thawing.
-
储存条件
- -20 °C
-
储存方法
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- Spartin (SPART)
-
别名
- SPART
-
背景
- SPG20, spastic paraplegia 20 (Troyer syndrome), KIAA0610, SPARTIN, TAHCCP1, OTTHUMP00000018254, spastic paraplegia 20, spastic paraplegia 20, spartin (Troyer syndrome), trans-activated by hepatitis C virus core protein 1
-
基因ID
- 23111
-
NCBI登录号
- NP_055902
抗原
-